Patient-based utilities for bipolar disorder-related health states

被引:29
|
作者
Revicki, DA
Hanlon, J
Martin, S
Laszlo, GC
Ghaemi, SN
Lynch, F
Mannix, S
Kleinman, L
机构
[1] United Biosource Corp, Ctr Hlth Outcomes Res, METAP Inst, Bethesda, MD 20814 USA
[2] J&J Pharmaceut Sci, Raritan, NJ USA
[3] Univ Penn, Biopolar Disorders Program, Philadelphia, PA 19104 USA
[4] Harvard Univ, Sch Med, Dept Psychiat, Cambridge Hosp, Cambridge, MA 02138 USA
[5] Kaiser Permanente, Ctr Hlth Res, Portland, OR USA
[6] MEDTAP Int, Ctr Hlth Outcomes Res, Seattle, WA USA
关键词
bipolar disorder; utility assessment; level of functioning; treatment-related side effects;
D O I
10.1016/j.jad.2005.03.017
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Bipolar disorder is a psychiatric disorder which impacts patient functioning and well-being. With increasing interest in cost-effectiveness of treatments, it is necessary to provide estimates of patient's perspectives on treatment outcomes. This study estimated health state utilities for hypothetical bipolar-related health states and patient's current health from bipolar I patients. Methods: Clinicians completed Young Mania Rating Scale, Montgomery-Asberg Depression Rating Scale, and Global Assessment Score. Patients completed structured standard gamble (SG) utility assessment interviews, and the other patient-based measures. Interviews obtained utilities for hypothetical bipolar-related health states describing symptom severity, functioning and well-being, and treatment-related side effects. Results: Ninety-six patients were recruited from psychiatry outpatient practices. Mean utilities for inpatient states ranged from 0.12 to 0.33; outpatient mania states ranged from 0.29 to 0.64; outpatient stable states ranged from 0.53 to 0.85. Mean utility for current health was 0.80 (S.D.=0.22). Patients preferred monotherapy compared with combination therapy health states. Ordinary least squares regression indicated weight gain was associated with a 0.066 decrease in health state utilities (P=0.013). Limitations: Study sample consisted of selected stable and educated patients and small sample sizes may limit generalizability for some utilities. Conclusions: Bipolar disorder patients are capable of participating in utility assessment and providing ratings for hypothetical health states associated with different mood stabilizer treatments. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:203 / 210
页数:8
相关论文
共 50 条
  • [21] Patient-Based Medicine: a New Concept for Health Care Services
    Rohrbacher, R.
    Marx, P.
    Schaufler, T.
    Schneider, H.
    GESUNDHEITSOEKONOMIE UND QUALITAETSMANAGEMENT, 2009, 14 (01): : 24 - 30
  • [22] Patient-based Measures of Illness Severity in the Veterans Health Study
    Clark, Jack A.
    Spiro, Avron
    Miller, Donald R.
    Fincke, B. Graeme
    Skinner, Katherine M.
    Kazis, Lewis E.
    JOURNAL OF AMBULATORY CARE MANAGEMENT, 2005, 28 (03): : 274 - 285
  • [23] ITGB4 deficiency in bronchial epithelial cells directs airway inflammation and bipolar disorder-related behavior
    Han, Li
    Wang, Leyuan
    Tang, Sha
    Yuan, Lin
    Wu, Shuangyan
    Du, Xizi
    Xiang, Yang
    Qu, Xiangping
    Liu, Huijun
    Luo, Huaiqing
    Qin, Xiaoqun
    Liu, Chi
    JOURNAL OF NEUROINFLAMMATION, 2018, 15
  • [24] Association of polysialic acid serum levels with schizophrenia spectrum and bipolar disorder-related structural brain changes and hospitalization
    Louisa Müller-Miny
    Katharina Thiel
    Susanne Meinert
    Tim Hahn
    Tilo Kircher
    Igor Nenadić
    Axel Krug
    Felix Hufschmidt
    Huan Liao
    Harald Neumann
    Udo Dannlowski
    Jan D. Lünemann
    Scientific Reports, 13
  • [25] ITGB4 deficiency in bronchial epithelial cells directs airway inflammation and bipolar disorder-related behavior
    Li Han
    Leyuan Wang
    Sha Tang
    Lin Yuan
    Shuangyan Wu
    Xizi Du
    Yang Xiang
    Xiangping Qu
    Huijun Liu
    Huaiqing Luo
    Xiaoqun Qin
    Chi Liu
    Journal of Neuroinflammation, 15
  • [26] Association of polysialic acid serum levels with schizophrenia spectrum and bipolar disorder-related structural brain changes and hospitalization
    Mueller-Miny, Louisa
    Thiel, Katharina
    Meinert, Susanne
    Hahn, Tim
    Kircher, Tilo
    Nenadic, Igor
    Krug, Axel
    Hufschmidt, Felix
    Liao, Huan
    Neumann, Harald
    Dannlowski, Udo
    Luenemann, Jan D.
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [27] Memantine-Related Psychotic Symptoms in a Patient With Bipolar Disorder
    Canan, Fatih
    Ataoglu, Ahmet
    JOURNAL OF CLINICAL PSYCHIATRY, 2010, 71 (07) : 957 - 957
  • [28] Acute Psychosis Related to Primary Hyperparathyroidism in a Patient With Bipolar Disorder
    Khan, Zahid
    Mlawa, Gideon
    Mahdi, Hussameldin
    Abumedian, Mohammed
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (07)
  • [29] Tramadol-related psychosis in a patient with bipolar I disorder
    Chen, Kuan-Jen
    Lu, Mong-Liang
    Shen, Winston W.
    ACTA NEUROPSYCHIATRICA, 2015, 27 (02): : 126 - 128
  • [30] PATIENT UTILITIES IN PARKINSON'S DISEASE IN HEALTH STATES BASED ON HOEHN AND YAHR AND OFF-TIME
    Norlin, J.
    Kellerborg, K.
    Odin, P.
    VALUE IN HEALTH, 2021, 24 : S170 - S171